Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions

被引:61
|
作者
Nikolsky, E
Mehran, R
Aymong, ED
Mintz, GS
Lansky, AJ
Lasic, Z
Negoita, M
Fahy, M
Pocock, SJ
Na, YB
Krieger, S
Moses, JW
Stone, GW
Leon, MB
Dangas, G
机构
[1] Cardiovasc Res Fdn, New York, NY 10022 USA
[2] Columbia Univ, Med Ctr, New York, NY 10022 USA
[3] London Sch Hyg & Trop Med, London WC1, England
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 08期
关键词
D O I
10.1016/j.amjcard.2004.06.058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Of 6,929 consecutive patients who were treated with percutaneous coronary intervention, 1,708 (24.6%) had anemia according to criteria of the World Health Organization. Compared with patients who did not have anemia, those who did have anemia were older, more frequently women and African-American, had a smaller body mass index, and higher frequencies of cardiovascular risk factors and co-morbid conditions. Patients who had anemia compared with those who did not have anemia had significantly (p < 0.0001) higher mortality rates during hospitalization (1.9% vs 0.4%) and at 1 year (12.8% vs 3.5%). After adjustment for potential confounders, baseline hematocrit remained a significant predictor of a 1-year mortality rate (hazard ratio 0.93 per 1% increase in hematocrit, 95% confidence interval 0.91 to 0.95). (C) 2004 by Excerpta Medical, Inc.
引用
收藏
页码:1023 / 1027
页数:5
相关论文
共 50 条
  • [41] Impact of Serum Fibrinogen Level on In-Hospital Outcomes in Patients Undergoing Percutaneous Coronary Interventions with Drug-Eluting Stents
    Ramasamy, Sureshkumar
    Rha, Seung-Woon
    Poddar, Kanhaiya L.
    Park, Ji Young
    Wang, Lin
    Choi, Byoung Geol
    Choi, Cheol Ung
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    CIRCULATION, 2010, 122 (02) : E136 - E136
  • [42] Impact of peripheral arterial disease on provision of discharge pharmacotherapy and longitudinal outcomes in patients with stable angina undergoing percutaneous coronary interventions
    Sorrentino, S.
    Baber, U.
    Chandrasekhar, Y.
    Zhen, G.
    Sartori, S.
    Kovacic, J.
    Moreno, P. R.
    Barman, N.
    Sweeney, J.
    Vijay, P.
    Giustino, G.
    Dangas, G.
    Mehran, R.
    Kini, A.
    Sharma, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 275 - 275
  • [43] Impact of glycoprotein IIb/IIIa inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions with sirolimus-eluting stents
    Nikolsky, Eugenia
    Holmes, David R.
    Mehran, Roxana
    Dangas, George
    Schampaert, Erick
    Morice, Marie-Claude
    Schofer, Joachim
    Sousa, J. Eduardo
    Donohoe, Dennis
    Moses, Jeffrey W.
    Leon, Martin B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 32B - 33B
  • [44] Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions
    Parikh, Devang
    Juergens, Craig P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 235 - 246
  • [45] Impact of anemia on clinical outcomes in patients with multivessel coronary artery disease treated with percutaneous coronary intervention
    Jonik, Szymon
    Skrobucha, Alicja
    Huczek, Zenon
    Kochman, Janusz
    Opolski, Grzegorz
    Grabowski, Marcin
    Mazurek, Tomasz
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2024, 20 (04): : 393 - 400
  • [46] Optimal timing for percutaneous coronary interventions in patients undergoing TAVI
    Venturi, Gabriele
    Lunardi, Mattia
    Del Sole, Paolo Alberto
    Pighi, Michele
    Scarsini, Roberto
    Ribichini, Flavio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [47] Predictors of stroke in patients undergoing percutaneous coronary interventions.
    Hajj-Ali, R
    Ezzeddine, R
    Park, C
    Katz, S
    Kaplan, B
    Marchant, D
    Green, S
    Ong, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 42G - 42G
  • [48] Optimal timing for percutaneous coronary interventions in patients undergoing TAVI
    Venturi, Gabriele
    Lunardi, Mattia
    Del Sole, Paolo Alberto
    Pighi, Michele
    Scarsini, Roberto
    Ribichini, Flavio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [49] Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
    Beitelshees, A. L.
    Horenstein, R. B.
    Vesely, M. R.
    Mehra, M. R.
    Shuldiner, A. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 455 - 459
  • [50] Comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary interventions
    Changezi, H
    Schweiger, MJ
    Prescod, D
    Cook, JR
    CIRCULATION, 1999, 100 (18) : 187 - 187